Aditxt (ADTX) News Today $0.99 -0.02 (-2.28%) As of 03:32 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ADTX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Evofem's "Say Vagina" Campaign Generates More than 2.5 Million Views Across Social Media PlatformsSeptember 11, 2025 | prnewswire.comEvofem Anticipates Approval of Merger with Aditxt at Upcoming Stockholder MeetingSeptember 9, 2025 | prnewswire.comAditxt’s Subsidiary Adimune Highlights Its Approach to Reprogramming the Immune System Through DNA Instructions, Now with 96 Granted and 22 Pending Patents Targeting ...August 26, 2025 | uk.finance.yahoo.comAditxt's Subsidiary Adimune Highlights Its Approach to Reprogramming the Immune System Through DNA Instructions, Now with 96 Granted and 22 Pending Patents Targeting Autoimmunity Market Estimated at Over $160 Billion by 2030August 25, 2025 | businesswire.comIllinois Pharmacists Can Prescribe PHEXXI Starting January 2026 Under Newly-passed LawAugust 21, 2025 | prnewswire.comFDA Orange Book Lists New U.S. Patent for SOLOSEC, Evofem Biosciences' "One and Done" Oral Treatment for Bacterial Vaginosis and TrichomoniasisAugust 19, 2025 | prnewswire.comADTX | Aditxt Inc. Annual Cash Flow Statement | MarketWatchAugust 14, 2025 | marketwatch.comEvofem Reports Positive Financial Results for Second Quarter of 2025, Provides Business UpdateAugust 14, 2025 | prnewswire.comEvofem CEO Saundra Pelletier Honored with Trailblazing Female Founders Award at STIMULATE ConferenceAugust 5, 2025 | prnewswire.comAditxt to Present at Wall Street Reporter's Next Super Stock Livestream Today July 22, 2025, at 1 p.m. ETJuly 22, 2025 | businesswire.comPhexxi -- A Non‑Hormonal Birth Control Brand -- Goes Viral with Microfeminism on TikTok, Featured by BuzzFeed and Scary MommyJuly 15, 2025 | prnewswire.comAditxt CEO Discusses Strategic Initiatives at LivestreamJuly 10, 2025 | tipranks.comAditxt Unveils bitXbio™: A Bitcoin-Backed Treasury Strategy Designed to Accelerate Biotech CommercializationJuly 8, 2025 | tmcnet.comAditxt Unveils bitXbioâ„¢: A Bitcoin-Backed Treasury Strategy Designed to Accelerate Biotech CommercializationJuly 7, 2025 | businesswire.comAditxt CEO Discusses Strategic Growth at Livestream EventJuly 3, 2025 | theglobeandmail.comAditxt, Inc. (ADTX) Latest Stock News & Headlines - Yahoo FinanceJune 26, 2025 | finance.yahoo.comAditxt to Present at Wall Street Reporter's NEXT SUPER STOCK Livestream Today June 26, 2025, at 1 p.m. ETJune 26, 2025 | businesswire.comNotable Data on Evofem's SOLOSEC in Recurrent Bacterial Vaginosis (BV) Released at ACOG Annual MeetingJune 11, 2025 | prnewswire.comEvofem Biosciences’ CEO Saundra Pelletier Joins Aditxt Board of DirectorsJune 9, 2025 | finance.yahoo.comEvofem Biosciences' CEO Saundra Pelletier Joins Aditxt Board of DirectorsJune 9, 2025 | businesswire.comSaundra Pelletier, Evofem Biosciences' CEO, Dr. Friedrich Kapp, Co-CEO of Adimune, and Chris Mitton, President of Pearsanta, Will Join Aditxt Weekly Update on June 6June 5, 2025 | businesswire.comAditxt Highlights Strategic Partnership with Evofem BiosciencesJune 2, 2025 | tipranks.comAditxt Announces Termination of Arrangement Agreement With Appili TherapeuticsMay 19, 2025 | finance.yahoo.comAditxt Discusses Strategic Focus and Growth PlansMay 19, 2025 | tipranks.comAppili Therapeutics Faces Termination of Agreement with AditxtMay 19, 2025 | tipranks.comAditxt Ends Agreement with Appili TherapeuticsMay 19, 2025 | tipranks.comAppili Therapeutics Provides Update on Arrangement with Aditxt, Inc.May 19, 2025 | financialpost.comFUpcoming Aditxt Weekly Update to Feature Dr. Shahrokh Shabahang, Chief Innovation Officer (CIO) of Aditxt™, and Dr. Friedrich Kapp, Co-CEO of Adimune™, to Discuss Progress of Lead Therapeutic Candidate ADI-100™May 2, 2025 | businesswire.comAditxt’s Subsidiary Pearsanta Gets IRB ApprovalApril 22, 2025 | tipranks.comDr. Charles Howe of the Mayo Clinic's Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt's Subsidiary Adimune™April 17, 2025 | businesswire.comAditxt Subsidiary Adimune Announces Positive Results from Mayo Clinic Pre-Clinical Studies to Support FDA and European Regulatory Submissions for Type 1 Diabetes, Psoriasis ...April 15, 2025 | seekingalpha.comAditxt Regains Nasdaq Compliance with Bid PriceApril 14, 2025 | tipranks.comAditxt announces results from ADI-100 studyApril 14, 2025 | markets.businessinsider.comAditxt Weekly Update to Highlight Recent Events, Including Regaining Compliance with Nasdaq Listing RequirementsApril 11, 2025 | businesswire.comWhy Aditxt Inc. (ADTX) Went Down On Thursday?April 10, 2025 | msn.comAditxt regains compliance with NasdaqApril 9, 2025 | msn.comAditxt, Inc. (NASDAQ: ADTX) Regains Compliance with Nasdaq Listing RequirementsApril 9, 2025 | finance.yahoo.comAditxt, Inc. Discusses Appili Therapeutics Acquisition PlansApril 7, 2025 | tipranks.comAppili Therapeutics CEO to join Aditxt CEO for weekly update on April 4April 3, 2025 | markets.businessinsider.comAditxt, Inc. Updates on Pearsanta’s Strategic AcquisitionMarch 31, 2025 | tipranks.comUpcoming Aditxt Weekly Update to Highlight Pearsanta's Acquisition of the Adductomics-Based CaSe Platform and its Potential for Early Cancer DetectionMarch 28, 2025 | businesswire.comAditxt Subsidiary Pearsanta Acquires Key Patents For Early Cancer DetectionMarch 26, 2025 | nasdaq.comEvofem Reports Fourth Consecutive Year of Net Sales GrowthMarch 24, 2025 | finance.yahoo.comAditxt, Inc. Highlights Strategic Partnership with EvofemMarch 24, 2025 | tipranks.comAditxt Insider Trading Activity | NASDAQ:ADTX | BenzingaMarch 19, 2025 | benzinga.comBiotech Stocks To Consider - March 18thMarch 19, 2025 | marketbeat.comAppili Therapeutics expects Aditxt transaction to close in Q1March 19, 2025 | markets.businessinsider.comUS Equities Markets End Lower Tuesday as Federal Reserve Kicks Off Policy MeetingMarch 18, 2025 | msn.comAditxt Stock Price, Quotes and Forecasts | NASDAQ:ADTX | BenzingaMarch 18, 2025 | benzinga.comADiTx Therapeutics trading halted, news pendingMarch 15, 2025 | markets.businessinsider.com Get Aditxt News Delivered to You Automatically Sign up to receive the latest news and ratings for ADTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ADTX Media Mentions By Week ADTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADTX News Sentiment▼0.630.94▲Average Medical News Sentiment ADTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADTX Articles This Week▼31▲ADTX Articles Average Week Get the Latest News and Ratings for ADTX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Aditxt and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Mannatech News Edesa Biotech News Hoth Therapeutics News LakeShore Biopharma News Abpro News iBio News Carisma Therapeutics News MetaVia News Minerva Neurosciences News Ainos News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ADTX) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aditxt, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aditxt With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
